Platelet-Rich Plasma (PRP) for Neuropathy

Platelet-rich plasma (PRP) therapy is a regenerative medicine approach that uses a concentrated preparation of your own platelets — injected at the site of damaged tissue — to deliver a high dose of growth factors that may stimulate tissue repair and nerve regeneration. Originally developed for sports medicine applications (tendons, ligaments, cartilage), PRP is now being investigated for peripheral neuropathy, particularly diabetic neuropathy and nerve entrapments such as carpal tunnel syndrome. The evidence base for neuropathy applications is preliminary — promising small studies exist, but large randomized controlled trials are limited. PRP should be considered an emerging option rather than a first-line treatment, and should only be pursued with a physician experienced in both neuropathy management and PRP administration.

How It Works

Platelets — the blood cells primarily responsible for clotting — contain hundreds of growth factors stored in granules. When a blood sample is centrifuged to concentrate the platelet fraction, the resulting PRP contains 3 to 10 times the platelet concentration of whole blood and a correspondingly elevated concentration of growth factors including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and nerve growth factor (NGF).

When injected at the site of nerve damage, these growth factors may stimulate Schwann cell activity (the cells that maintain myelin), promote axonal regrowth, reduce local inflammation, and improve microvascular blood flow to the damaged nerve tissue. For peripheral neuropathy, injection can be targeted perineural (around the nerve) using ultrasound guidance — placing growth factors in close proximity to the damaged nerve fibers without penetrating the nerve itself.

Evidence for Neuropathy

For carpal tunnel syndrome — a nerve entrapment neuropathy at the wrist — PRP evidence is the strongest in the peripheral nerve category. Multiple randomized controlled trials have compared ultrasound-guided perineural PRP injection to corticosteroid injection, with several finding PRP superior at 3 to 6 months on symptom scores and nerve conduction parameters. A 2020 systematic review in Pain Medicine concluded that PRP injections produced significant improvements in nerve conduction velocity and symptom scores for carpal tunnel syndrome.

For diabetic peripheral neuropathy, evidence is more preliminary. A 2018 pilot RCT found that intraneural PRP improved nerve conduction parameters and reduced pain scores compared to saline control at 6 months. A 2020 study of perineural PRP for diabetic neuropathy showed improvements in both pain and vibration threshold testing. These are promising results but from small trials — larger definitive trials are needed before PRP can be recommended as standard care for diffuse diabetic neuropathy.

For postherpetic neuralgia and other focal nerve pain conditions, case series and small studies report relief, but controlled evidence is sparse.

The Procedure

PRP preparation involves drawing a blood sample (typically 15 to 60 mL) from the patient’s arm, centrifuging it in a specialized system to separate and concentrate the platelet layer, and then preparing the PRP for injection. The centrifugation and preparation process takes approximately 15 to 20 minutes. The resulting PRP volume is typically 3 to 8 mL.

For peripheral neuropathy applications, PRP is injected perineural (around the nerve) under ultrasound guidance — this real-time imaging allows precise needle placement adjacent to the target nerve without intraneural injection. The procedure is typically well-tolerated with local anesthetic applied to the skin. Some post-injection soreness and swelling at the injection site is expected for 24 to 72 hours.

Protocols vary among practitioners — some use a single injection, others use a series of 2 to 4 injections spaced 4 to 6 weeks apart. There is no standardized PRP preparation or injection protocol for neuropathy, which makes interpretation of results across different studies challenging.

Limitations and Considerations

PRP therapy for peripheral neuropathy has several important limitations to discuss with your physician. First, there is no standardized PRP preparation — different centrifugation systems produce platelet concentrations, leukocyte content, and growth factor profiles that vary substantially between manufacturers and practices. Second, insurance coverage for PRP in neuropathy is limited or absent at most payers — expect out-of-pocket costs of $500 to $2,000 per injection depending on the clinic and region.

Third, the evidence base, while promising, is preliminary for most neuropathy applications outside of carpal tunnel syndrome. Fourth, patient selection matters significantly — patients with active systemic infection, platelet disorders, anticoagulation therapy, or certain cancers are not appropriate candidates. A thorough evaluation by a physician with specific PRP experience is necessary before proceeding.

Frequently Asked Questions

Is PRP therapy painful for neuropathy?

The injection procedure itself is typically well-tolerated with local anesthetic. Post-injection soreness and swelling at the injection site are expected for 24 to 72 hours — many patients describe this as similar to a mild bruise. The nerve itself is not injected (perineural injection places PRP adjacent to, not inside, the nerve), which minimizes the risk of sharp nerve pain during the procedure.

How many PRP injections are needed for neuropathy?

There is no established standard protocol. Some practitioners use a single injection and assess response at 4 to 8 weeks. Others use a series of 2 to 4 injections over several months. The optimal number of injections likely depends on the severity of nerve damage, the specific neuropathy type, and individual patient response. Discuss the planned protocol and criteria for assessing treatment success with your physician before committing to a multi-injection course.

Can PRP replace surgery for carpal tunnel syndrome?

For mild to moderate carpal tunnel syndrome, PRP injection may provide relief comparable to corticosteroid injection, with some evidence of longer duration of benefit. Surgical decompression remains the most effective intervention for moderate to severe carpal tunnel with significant nerve damage or symptoms that have failed conservative management. PRP may delay or, in some patients, avoid surgery — but is not an appropriate substitute for surgical decompression when nerve damage is severe or when electrophysiological studies show advanced median nerve injury.